Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Stress stops hair growth in mice by causing early hair growth phase end and harmful inflammation through a specific nerve-related pathway.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Capsaicin, found in chili peppers, can slow down hair growth by affecting skin cells and hair follicles.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Key genes and pathways crucial for hair follicle development in cashmere goats were identified, aiding fleece production improvement.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

The document concludes that hair is complex, with a detailed growth cycle, structure, and clinical importance, affecting various scientific and medical fields.

We need more research to better understand human hair follicle stem cells for improved treatments for hair loss and skin cancer.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Macrophages are vital for skin healing, hair growth, salt balance, and cancer defense.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Blocking Wnt signaling in young mice causes thymus shrinkage and cell loss, but recovery is possible when the block is removed.

Research on epidermal stem cells has advanced significantly, showing promise for improved clinical therapies.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.